Overview

Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin

Status:
Completed
Trial end date:
2018-04-28
Target enrollment:
0
Participant gender:
All
Summary
Comparative safety study of intracameral levofloxacin versus moxifloxacin for postoperative infection prophylaxis
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Peregrine Eye and Laser Institute
Treatments:
Levofloxacin
Moxifloxacin
Ofloxacin
Criteria
Inclusion Criteria:

- Eyes undergoing uncomplicated cataract surgery by phacoemulsification

Exclusion Criteria:

- Corneal opacities, corneal dystrophies, glaucoma, uveitis, retinopathy, optic
neuropathy, concomitant infection (blepharitis, hordeolum, or conjunctivitis) or
uncontrolled systemic disease and intraoperative complications that may affect visual
outcomes were excluded from the study